When Clinical Trial Results Just Say 'No'
March 12, 2007 | Nuvelo Inc. CEO Ted Love remembers hearing the bad news over the phone in December and thinking it must be a joke. Love was convinced that his San Carlos biotech company's experimental drug alfimeprase would prove effective against dangerous blood clots. He reeled when he was told that data from two big clinical trials showed otherwise. Story in The San Francisco Chronicle.
Feeds